Agreement - January 13, 2015
MedImmune, Omnis Connect
AstraZeneca’s global biologics research and development arm, MedImmune, has entered into a licensing agreement with Omnis Pharmaceuticals, a privately-held biotechnology company focused on the development of oncolytic viruses. This agreement will allow MedImmune to combine key agents from its investigational immunotherapy portfolio with Omnis’ lead investigational oncolytic virus program, a genetically engineered strain of vesicular […]
Agreement - January 13, 2015
Thermo Scientific Extends Reach
Mohammad Abdullah Al Azzaz Company Limited has implemented Thermo Scientific™ SampleManager LIMS™, an informatics solution for process industries worldwide, to enhance the services offered through the company’s contract testing laboratories. MAAZ is a strategic partner to key contractors in the Middle East focused on serving industry involved with construction material testing, chemical and environmental testing […]
Agreement - January 8, 2015
Sobi, Exelixis Extend Agreement
Swedish Orphan Biovitrum AB (Sobi) has restructured and extended an agreement with Exelixis, Inc. to December 31, 2019. Sobi is responsible for the commercialization and distribution of Cometriq® (cabozantinib) for progressive, unresectable, locally advanced or metastatic medullary thyroid cancer (MTC) in the European Union (EU), Switzerland, Norway, Russia and Turkey. The collaboration originated in February […]
Agreement - December 16, 2014
Firm to Market Blood Purification Therapy in Nordic Countries
CytoSorbents Corporation announced that it has entered into a multi-country strategic partnership with Fresenius Medical Care AG & CO KGaA to commercialize CytoSorbents’ CytoSorb® therapy in the Nordic countries. Under the terms of the agreement, Fresenius Medical Care will have the exclusive rights to distribute CytoSorb® for critical care applications in France, Poland, Sweden, […]
Agreement - December 10, 2014
MSD, Denmark to Partner
Life sciences company MSD (known as Merck in the U.S. and Canada) has entered into a strategic partnership with the University of Copenhagen and the Capital Region. The Capital Region is one of five regional governing bodies in Denmark assigned to region-wide issues such as health care. This strategic partnership comes soon after a similar agreement with Novartis […]
Agreement - December 8, 2014
SyntheticMR signs license agreement with GE Healthcare
SyntheticMR has entered into a license agreement with GE Healthcare regarding SyMRI IMAGE. The agreement gives GE the right to sell a customized version of SyntheticMR’s software directly to its customers globally. GE Healthcare is now introducing the software, which is marketed under the name MAGiC, at RSNA. In the quarterly report for the second […]
